Notably, although CD96 was also expressed by T cells, the control of metastases by an anti-CD96 mAb appeared to be dependent on NK cells, CD226 and IFN-γ production (63), suggesting a non-negligible role for NK cells in cancer immunotherapy. Here, CD96 is linked to cancer.